These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4048798)

  • 61. Subpopulations of T lymphocytes in patients with chronic active liver disease.
    Burrai I; Carbone A
    Ric Clin Lab; 1982; 12(3):501-6. PubMed ID: 6982500
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [The role of immune complexes in chronic liver diseases and their dynamics during treatment].
    Iakhontova OI; Dudanova OP
    Ter Arkh; 1992; 64(2):10-5. PubMed ID: 1509358
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Chronic active hepatitis associated with polymyositis. Association with precipitating mitochondrial M-B antibody.
    Bradley JD; Pinals RS; Gupta RC
    J Rheumatol; 1985 Apr; 12(2):368-71. PubMed ID: 4032411
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Humoral and cellular immune reactions in acute and chronic liver diseases].
    Szécsey G; Nyerges G; Hollós I; Lászlo B; Ibrányi E
    Orv Hetil; 1975 Mar; 116(11):613-5. PubMed ID: 1118133
    [No Abstract]   [Full Text] [Related]  

  • 65. [Effect of glucocorticoids on immunological indices in patients with subacute thyroiditis].
    Epishin AV; Svider IO; Rapita OD
    Vrach Delo; 1989 Apr; (4):29-31. PubMed ID: 2756679
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Azathioprine versus prednisone in non-alcoholic chronic liver disease (CLD). Relation to a serological classification.
    Tage-Jensen U; Schlichting P; Aldershvile J; Andersen P; Dietrichson O; Hardt F; Mathiesen LR; Nielsen JO
    Liver; 1982 Jun; 2(2):95-103. PubMed ID: 7176845
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Treatment of patients with hypertonic disease with plasmapheresis].
    Kim IS; Amanchenko VG; Kuznetsov SV; Strizhova NV; Malashenkova IK; Alizade IG
    Klin Med (Mosk); 1989 Jul; 67(7):40-3. PubMed ID: 2811212
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Effect of immunodepressant treatment on immune deviations in chronic hepatitis].
    Nicolaescu T; Bordea M; Bordeianu A; Bittman E; Stoiculescu P; Udrescu E
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985; 37(6):521-8. PubMed ID: 2871610
    [No Abstract]   [Full Text] [Related]  

  • 69. [Variations of treatment of chronic alcohol diffusion liver disease].
    Khvorostinka VM; Il'chenko IA; Bobronnikova LR
    Lik Sprava; 2001; (3):154-5. PubMed ID: 11560009
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antibody dependent cellular cytotoxicity in chronic active liver diseases.
    Kakumu S; Hotta R; Kuriki J
    Gastroenterol Jpn; 1981; 16(4):372-6. PubMed ID: 7286562
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [The clinico-immunological efficacy of the new drug preparation Erbisol in patients with chronic hepatitis].
    Bychkova NG; Shipulin VP; Fomina AA; Bychkova SA
    Lik Sprava; 1995; (3-4):65-7. PubMed ID: 8819925
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prednisone treatment of chronic liver disease. I. Chronic aggressive hepatitis as a therapeutic marker.
    Schlichting P; Fauerholdt L; Christensen E; Poulsen H; Juhl E; Tygstrup N
    Liver; 1982 Jun; 2(2):104-12. PubMed ID: 7176839
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antibody dependent cytotoxicity in chronic active liver disease.
    Banciu T; Arcan P
    Gastroenterol Jpn; 1988 Dec; 23(6):695-7. PubMed ID: 3220246
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [The pathogenetic role of a natural inhibiting factor in acute and chronic liver diseases of viral etiology].
    Frolov VM; Petrunia AM; Pinskiĭ LL
    Lik Sprava; 1996; (7-9):84-6. PubMed ID: 9072277
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The detrimental effects of adrenocorticosteroid therapy in HBsAg-positive chronic active hepatitis: fact or artifact?
    Conn H; Maddrey WC; Soloway RD
    Hepatology; 1982; 2(6):885-7. PubMed ID: 7141399
    [No Abstract]   [Full Text] [Related]  

  • 76. [Chronic hepatitis B exacerbation following a short prednisone therapy resulting in death].
    Laskus T; Cianciara J; Slusarczyk J; Lupa E
    Pol Tyg Lek; 1991 Apr 1-15; 46(14-16):277-8. PubMed ID: 1669052
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [EFFECTS OF CORTICOTHERAPY ON THE IMMEDIATE AND EVENTUAL COURSE OF ICTERIGENIC VIRAL HEPATITIS IN AFRICANS. APROPOS OF 7 CASES OF SCLEROGENIC CHRONIC HEPATITIS AND 8 CASES OF POSTHEPATITIC CIRRHOSIS AMONG 110 CASES].
    REYNAUD R; DUFOUR P; MASSAT R; PICCA M; ONDE M; REVIL H; HUBERT M
    Bull Soc Pathol Exot Filiales; 1964; 57():82-104. PubMed ID: 14185715
    [No Abstract]   [Full Text] [Related]  

  • 78. [Changes in the immunological indices of patients with obstructive jaundice and liver cirrhosis during the extracorporeal connection of a pig spleen].
    Arynova RS; Bazhenov LG; Kornienko VI
    Klin Khir (1962); 1994; (3):25-7. PubMed ID: 7637283
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Immune changes in subacute thyroiditis].
    Epishin AV; Svider IO
    Vrach Delo; 1986 Aug; (8):59-62. PubMed ID: 3776164
    [No Abstract]   [Full Text] [Related]  

  • 80. [Effect of the enteral adsorbent polifepan on the homeostatic system during prolonged use].
    Beliakov NA; Levanova VP; Shabanova LF; Sirotina VV; Smirnova LA
    Fiziol Zh (1978); 1988; 34(3):83-8. PubMed ID: 3410122
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.